HAHN MARK W (Chief Financial Officer) sold 13.6% of their position (1.54K shares) of DOVA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $21.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2019ACC: 0001209191-19-040381
Officer· Chief Financial Officer
Since Oct 2018
-1.54K
Net shares
Net seller
$21.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.54K
Price / share
$14.17
Trade value
$21.89K
% of position
13.6%
7/1/2019
11.34K→9.80K
Total
Net shares
−1.54K
Net value
-$21.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2019 | S · Sale | −1.54K | $14.17 | $21.89K | 13.6% | 11.34K | 9.80K |
| Total | −1.54K | -$21.89K | ||||||
Derivative Transactions0
No derivative transactions reported